Skip to main content
. Author manuscript; available in PMC: 2008 Jun 21.
Published in final edited form as: Neurosci Lett. 2007 May 16;421(1):27–32. doi: 10.1016/j.neulet.2007.05.020

Figure 2. FGF2 enhances Hes5 promoter activity in OP cells.

Figure 2

OP cells were transfected using plasmids with luciferase reporter transcription driven by the promoter region for Hes1 or Hes5. On the following day, the cultures were transferred to defined medium with (+) or without (−) FGF2 for 10 hrs and transcription activity was then measured as relative luciferase units (RLU). FGF2 treatment increased the Hes5 promoter activity approximately 4-fold (*p < 0.001) but did not alter Hes1 promoter (p > 0.05). Values (mean ± standard error of the mean) are from duplicate wells of three independent experiments.